# Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

> **NCT01868555** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 32 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** insulin degludec
- **DRUG:** insulin degludec/insulin aspart 30
- **DRUG:** insulin degludec/insulin aspart 45
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01868555
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868555, "Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01868555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*